Mesenchymal Stem Cells Display Hepato-protective Activity in Lymphoma Bearing Xenografts
Overview
Authors
Affiliations
A disseminated model of non-Hodgkin's lymphoma with prevalent liver metastasis was generated by intraperitoneal (i.p.) injection of EBV(+) B lymphoblastoid SKW6.4 in nude-SCID mice. The survival of SKW6.4 xenografts (median survival = 27 days) was significantly improved when hyaluronan scaffolds embedded with mesenchimal stem cells (MSC) were implanted in the abdominal area 4 days after SKW6.4 injection (median survival = 39.5 days). Mice implanted with MSC showed a significant improvement of hepatic functionality in lymphoma xenografts, as demonstrated by measurement of serum ALT/AST levels. Co-culture of MSC with lymphoma cells enhanced the release of hepatocyte growth factor (HGF) by MSC. These data suggest that hyaluronan-embedded MSC exert anti-lymphoma activity by ameliorating hepatic functionality.
Immunological effect induced by mesenchymal stem cells in a rat liver transplantation model.
Sun Z, Li T, Wen H, Wang H, Ji W, Ma Y Exp Ther Med. 2015; 10(2):401-406.
PMID: 26622328 PMC: 4509065. DOI: 10.3892/etm.2015.2551.
Li P, Zhang J, Liu J, Ma H, Liu J, Lie P Tissue Eng Part A. 2014; 21(3-4):603-15.
PMID: 25273546 PMC: 4333318. DOI: 10.1089/ten.TEA.2013.0331.
Gardin C, Vindigni V, Bressan E, Ferroni L, Nalesso E, Della Puppa A Int J Mol Sci. 2011; 12(10):6749-64.
PMID: 22072917 PMC: 3211008. DOI: 10.3390/ijms12106749.